OMNICELL, INC. — Director's Dealing 2017

Aug 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2017-08-15

Reporting Person: Seim Robin Gene (EVP, Global A & M Adherence)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-15	Common Stock	S	2248	$50.8992	Disposed	55896	Direct
2017-08-15	Common Stock	S	12861	$50.8562	Disposed	43035	Direct
2017-08-15	Common Stock	M	12861	—	Acquired	55896	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-15	Non qualified option (right to buy)	$25.08	M	8850	Acquired	2024-02-04	Common Stock (8850)	Direct
2017-08-15	Non qualified Option (right to buy)	$17.29	M	4011	Acquired	2023-02-05	Common Stock (4011)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	58144	Direct

Footnotes

F1: The price reported in Column 4 is the average price of $50.8992. The shares sold between $50.45 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is the average price of $50.85620. The shares sold between $50.50 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.